{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:14:19Z","timestamp":1787022859782,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["GJHZ20210705141400002"],"award-info":[{"award-number":["GJHZ20210705141400002"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818101615033"],"award-info":[{"award-number":["JCYJ20220818101615033"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KCXFZ20211020164543006"],"award-info":[{"award-number":["KCXFZ20211020164543006"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830040"],"award-info":[{"award-number":["81830040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130042"],"award-info":[{"award-number":["82130042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011498","name":"Shaoxing Science Technology Bureau","doi-asserted-by":"publisher","award":["2022KY015"],"award-info":[{"award-number":["2022KY015"]}],"id":[{"id":"10.13039\/501100011498","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LGD22H090016"],"award-info":[{"award-number":["LGD22H090016"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF18H090018"],"award-info":[{"award-number":["LGF18H090018"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jad.2023.12.074","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T06:49:28Z","timestamp":1705301368000},"page":"761-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis"],"prefix":"10.1016","volume":"350","author":[{"given":"Zhaowei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2023.12.074_bb0005","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1523\/JNEUROSCI.0398-18.2018","article-title":"Reduced microglial activity and enhanced glutamate transmission in the basolateral amygdala in early CNS autoimmunity","volume":"38","author":"Acharjee","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jad.2023.12.074_bb0010","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.3390\/molecules27238448","article-title":"Emerging potential of the phosphodiesterase (PDE) inhibitor ibudilast for neurodegenerative diseases: an update on preclinical and clinical evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jad.2023.12.074_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1128190","article-title":"Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases","volume":"14","author":"Boraschi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jad.2023.12.074_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psyneuen.2018.01.002","article-title":"Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers","volume":"89","author":"Brenner","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2023.12.074_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14200","article-title":"Electroacupuncture alleviated depression-like behaviors in ventromedial prefrontal cortex of chronic unpredictable mild stress-induced rats: increasing synaptic transmission and phosphorylating dopamine transporter","author":"Cai","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2023.12.074_bb0030","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jad.2023.12.074_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113568","article-title":"Higher levels of serum IL-1\u03b2 and TNF-\u03b1 are associated with an increased probability of major depressive disorder","volume":"295","author":"Das","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2023.12.074_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41423-018-0186-9","article-title":"Upregulation of CD81 in trophoblasts induces an imbalance of Treg\/Th17 cells by promoting IL-6 expression in preeclampsia","volume":"16","author":"Ding","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jad.2023.12.074_bb0045","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.neubiorev.2005.03.023","article-title":"Cytokines as mediators of depression: what can we learn from animal studies?","volume":"29","author":"Dunn","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2023.12.074_bb0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.0803576","article-title":"Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells","volume":"183","author":"Ellestad","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jad.2023.12.074_bb0055","article-title":"Roles and regulation of microglia activity in multiple sclerosis: insights from animal models","author":"F","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2023.12.074_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan Chung","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2023.12.074_bb0065","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1352458517702553","article-title":"Multiple sclerosis and suicide","volume":"23","author":"Feinstein","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jad.2023.12.074_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"Filippi","year":"2018","journal-title":"Multiple sclerosis. Nat Rev Dis Primers"},{"key":"10.1016\/j.jad.2023.12.074_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105817","article-title":"Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis","volume":"172","author":"Gilio","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2023.12.074_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118582","article-title":"Fingolimod suppressed the chronic unpredictable mild stress-induced depressive-like behaviors via affecting microglial and NLRP3 inflammasome activation","volume":"263","author":"Guo","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jad.2023.12.074_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jad.2023.12.074_bb0090","article-title":"Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)","volume":"14","author":"H","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jad.2023.12.074_bb0095","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.12.074_bb0100","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.4103\/1673-5374.235222","article-title":"Seeing the wood for the trees: towards improved quantification of glial cells in central nervous system tissue","volume":"13","author":"Healy","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jad.2023.12.074_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00106","article-title":"Automated morphological analysis of microglia after stroke","volume":"12","author":"Heindl","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jad.2023.12.074_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11910-019-0992-1","article-title":"Depression and suicidality in multiple sclerosis: red flags, management strategies, and ethical considerations","volume":"19","author":"Kalb","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jad.2023.12.074_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/med.21973","article-title":"Reconsidering the route of drug delivery in refractory multiple sclerosis: toward a more effective drug accumulation in the central nervous system","author":"Kalkowski","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jad.2023.12.074_bb0120","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.3390\/ijms24097960","article-title":"Autoimmune neuroinflammatory diseases: role of interleukins","volume":"24","author":"Khan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jad.2023.12.074_bb0125","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/brain\/123.2.308","article-title":"Axonal changes in chronic demyelinated cervical spinal cord plaques","volume":"123","author":"Lovas","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jad.2023.12.074_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)62410-7","article-title":"Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial","volume":"385","author":"Martinez","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2023.12.074_bb0135","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2023.09.004","article-title":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: an experimental, placebo-controlled study","volume":"114","author":"Mason","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.12.074_bb0140","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200154","article-title":"Clinical practice guidelines for the detection and treatment of depression in multiple sclerosis: a systematic review","volume":"13","author":"McIntosh","year":"2023","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.jad.2023.12.074_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.msard.2017.10.004","article-title":"Treating depression in multiple sclerosis with antidepressants: a brief review of clinical trials and exploration of clinical symptoms to guide treatment decisions","volume":"18","author":"Nathoo","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jad.2023.12.074_bb0150","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jad.2023.12.074_bb0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.autrev.2015.11.005","article-title":"Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration","volume":"15","author":"Patejdl","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jad.2023.12.074_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2021.07.011","article-title":"TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice","volume":"175","author":"Peres","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jad.2023.12.074_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2022.100484","article-title":"Prevalence of depression and anxiety in the different clinical forms of multiple sclerosis and associations with disability: a systematic review and meta-analysis","volume":"24","author":"Peres","year":"2022","journal-title":"Brain, Behavior, & Immunity - Health"},{"key":"10.1016\/j.jad.2023.12.074_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108358","article-title":"Adrenoceptors as potential target for add-on immunomodulatory therapy in multiple sclerosis","volume":"243","author":"Pilipovi\u0107","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jad.2023.12.074_bb0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/biomedicines9070703","article-title":"Neuroinflammation in ischemic stroke: inhibition of cAMP-specific phosphodiesterases (PDEs) to the rescue","volume":"9","author":"Ponsaerts","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jad.2023.12.074_bb0180","article-title":"Targeting microglia-oligodendrocyte crosstalk in neurodegenerative and psychiatric disorders","volume":"27","author":"R","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jad.2023.12.074_bb0185","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S2213-2600(18)30331-X","article-title":"Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial","volume":"6","author":"Rabe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jad.2023.12.074_bb0190","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1474-4422(18)30309-0","article-title":"The hippocampus in multiple sclerosis","volume":"17","author":"Rocca","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2023.12.074_bb0195","article-title":"Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics","volume":"14","author":"S","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jad.2023.12.074_bb0200","doi-asserted-by":"crossref","unstructured":"Saitoh, B.-Y., Tanaka, E., Yamamoto, N., Kruining, D. van, Iinuma, K., Nakamuta, Y., Yamaguchi, H., Yamasaki, R., Matsumoto, K., Kira, J.-I., 2021. Early postnatal allergic airway inflammation induces dystrophic microglia leading to excitatory postsynaptic surplus and autism-like behavior. Brain Behav. Immun. 95, 362\u2013380. doi:https:\/\/doi.org\/10.1016\/j.bbi.2021.04.008.","DOI":"10.1016\/j.bbi.2021.04.008"},{"key":"10.1016\/j.jad.2023.12.074_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2022.12.020","article-title":"Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis","volume":"109","author":"Schepers","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2023.12.074_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1231031","article-title":"Association of interleukin-6 with suicidal ideation in veterans: a longitudinal perspective","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.074_bb0215","doi-asserted-by":"crossref","DOI":"10.1177\/11795735221098143","article-title":"Determining prevalence of depression and covariates of depression in a cohort of multiple sclerosis patients","volume":"14","author":"Tardo","year":"2022","journal-title":"J Cent Nerv Syst Dis"},{"key":"10.1016\/j.jad.2023.12.074_bb0220","article-title":"Chronic demyelination and axonal degeneration in multiple sclerosis: pathogenesis and therapeutic implications","volume":"21","author":"Tj","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jad.2023.12.074_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68770-0","article-title":"High-resolution and differential analysis of rat microglial markers in traumatic brain injury: conventional flow cytometric and bioinformatics analysis","volume":"10","author":"Toledano Furman","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2023.12.074_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2023.09.006","article-title":"Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: a systematic-review and meta-analysis","volume":"78","author":"V\u00f6ckel","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.12.074_bb0235","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2011.07.047","article-title":"Early-life exposure to lipopolysaccharide reduces the severity of experimental autoimmune encephalomyelitis in adulthood and correlated with increased urine corticosterone and apoptotic CD4+ T cells","volume":"193","author":"Wang","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.jad.2023.12.074_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104892","article-title":"Early postnatal tobacco smoke exposure aggravates experimental autoimmune encephalomyelitis in adult rats","volume":"141","author":"Wang","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2023.12.074_bb0245","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ijnp\/pyaa048","article-title":"The phosphodiesterase-4 inhibitor roflumilast, a potential treatment for the comorbidity of memory loss and depression in Alzheimer\u2019s disease: a preclinical study in APP\/PS1 transgenic mice","volume":"23","author":"Wang","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2023.12.074_bb0250","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","article-title":"Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2023.12.074_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-021-01571-9","article-title":"Beneficial effects of running exercise on hippocampal microglia and neuroinflammation in chronic unpredictable stress-induced depression model rats","volume":"11","author":"Xiao","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2023.12.074_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2023.04.074","article-title":"Transcriptome comparative analysis of amygdala-hippocampus in depression: a rat model induced by chronic unpredictable mild stress (CUMS)","author":"Yang","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2023.12.074_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121806","article-title":"Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK\/mTOR\/ULK1-dependent autophagy pathway","volume":"327","author":"Zaki","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jad.2023.12.074_bb0270","doi-asserted-by":"crossref","first-page":"9322","DOI":"10.1080\/21655979.2022.2052671","article-title":"Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88\/PI3K\/Akt\/NF-\u03baB signalling pathway","volume":"13","author":"Zheng","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.jad.2023.12.074_bb0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-023-02901-y","article-title":"Noteworthy perspectives on microglia in neuropsychiatric disorders","volume":"20","author":"Zhu","year":"2023","journal-title":"J. Neuroinflammation"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723015434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032723015434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:43:17Z","timestamp":1762789397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032723015434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":55,"alternative-id":["S0165032723015434"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2023.12.074","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roflumilast: Modulating neuroinflammation and improving motor function and depressive symptoms in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2023.12.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}